Epidemiology

Covid-19 vaccination

17,01,2021 Covid-19 vaccination in the world

With the start of the distribution of Corona vaccine in different countries of the world, many high-risk groups including medical staff and the elderly in different countries of the world as well as eight countries in the region including Saudi Arabia, UAE, Kuwait, Bahrain, Israel, Qatar, Oman and Turkey. They have received a dose of this vaccine.

AstraZeneca COVID-19 vaccine

AstraZeneca COVID-19 vaccine

AstraZeneca’s COVID-19 vaccine authorized for emergency supply in the UK

 COVID-19 vaccine(AstraZeneca COVID-19 vaccine)in collaboration with the University of Oxford said it has developed a formula that protects citizens 100% against severe coronary heart disease, which leads to hospitalization. Pfizer and modern vaccines are equal.

SARS-CoV-2

Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/ΔV70

Abstract SARS-CoV-2 Spike amino acid replacements in the receptor binding domain (RBD) occur relatively frequently and some have a consequence for immune recognition. Here we report recurrent emergence and significant …

Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/ΔV70 Read More »

oxford astrazeneca covid-19 vaccine results expected by christmas

Oxford-AstraZeneca COVID-19 vaccine results expected by Christmas University of Oxford scientists expect to report results from late-stage trials of the COVID-19 vaccine it is developing with AstraZeneca by late December. …

oxford astrazeneca covid-19 vaccine results expected by christmas Read More »

COVID-19 Vaccine

Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine

PFIZER AND BIONTECH CONCLUDE PHASE 3 STUDY OF COVID-19 VACCINE CANDIDATE, MEETING ALL PRIMARY EFFICACY ENDPOINTS Wednesday, November 18, 2020 – 06:59am Primary efficacy analysis demonstrates BNT162b2 to be 95% …

Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Read More »

Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)

Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)

Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273) Interim analysis of original cohorts of Phase 1 …

Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273) Read More »